ANI Pharmaceuticals, Inc. (ANIP) Q2 2026 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good day, everyone, and welcome to today's ANI Pharmaceuticals, Inc. Second Quarter twenty twenty six Earnings Results Call. Please note this call is being recorded. After the speakers' prepared remarks, there will be a question and answer session. It It is now my pleasure to turn the conference over to Irina Please go ahead. Thank you, Daniel. Welcome to ANI Pharmaceuticals Second Quarter twenty twenty six Earnings Results Call. This is Irina Koffler, Investor Relations for ANI. With me on today's call are Nikhil Alwani, President and Chief Executive Officer Stephen Carey, Senior Vice President and Chief Financial Officer and Chris Motts, Senior Vice President and Head of ANI's Rare Disease business. Earlier this morning on 08/07/2026, we released our results for the second quarter twenty twenty six via a press release that is available on our website. This call is also available via webcast and is accompanied by a slide deck that can be accessed by going to the Events section of the Investors page of our website. Before we begin, I would like to remind you that we will be making forward looking statements and discussing certain non GAAP measures. Forward looking statements are subject to substantial risks and uncertainties, speak only to the call's original date, and we take no obligation to update or revise any of the statements. During this call, we will also refer to certain non GAAP financial measures to describe our performance and have provided a reconciliation to the most directly comparable GAAP financial measures within the materials that accompany this call. The archived webcast will be available for thirty days on our website, anipharmaceuticals.com. And with that, I'll turn the call over to Nikhil Awani. Thank you, Irina. Good morning, everyone, and tha...